EEG Feature Extraction for TMS Efficacy Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for depression, particularly transcranial magnetic stimulation, are not universally effective and are costly, leading to ineffective treatments and high medical expenses due to the lack of a reliable method to determine efficacy before administration.
Innovation Solution
An auxiliary determination device that extracts feature values from electroencephalography signals using a machine learning unit, comprising a feature extraction unit, signal pre-processing unit, and frequency band screening unit, to evaluate the effectiveness of transcranial magnetic stimulation and adjust parameters for personalized treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If transcranial magnetic stimulation is used to treat depression, then treatment period is significantly shorter than drugs or psychological counseling, but the treatment cost is higher and not effective for every patient
Solution Approach 1:
The system performs preliminary analysis of EEG signals before TMS treatment to predict treatment efficacy. By extracting features from EEG signals and inputting them into a trained machine learning model, the system determines in advance whether a patient is likely to respond well to TMS therapy, allowing doctors to avoid ineffective treatments and select appropriate candidates before administering the expensive treatment.
2Reliability
If transcranial magnetic stimulation parameters are adjusted to generate r-TMS or i-TBS, then treatment effectiveness may be improved, but the complexity of parameter settings increases
Solution Approach 1:
The system automatically determines the appropriate TMS parameters based on the patient's EEG signal characteristics and the pre-trained machine learning model. Instead of requiring doctors to manually adjust multiple parameters, the system self-service by selecting optimal parameters (such as frequency, intensity, and pulse pattern) based on the patient's neural activity patterns, thereby simplifying the operation while maintaining treatment effectiveness.
Solution Approach 2:
The system changes TMS parameters dynamically based on individual patient characteristics extracted from EEG signals. The machine learning model analyzes features such as brain wave frequencies and patterns to automatically adjust parameters like stimulation frequency, pulse width, and intensity to match the patient's specific neural characteristics, thereby optimizing treatment effectiveness without requiring manual parameter tuning.
3Measurement precision
If EEG signal analysis is performed with multiple processing steps including pre-processing, feature extraction, and frequency band screening, then evaluation accuracy is improved, but the system complexity increases
Solution Approach 1:
The signal analysis system is divided into distinct functional modules: pre-processing unit for noise reduction and signal conditioning, feature extraction unit for identifying relevant EEG characteristics, frequency band screening unit for isolating specific frequency ranges, and classification unit for predicting treatment response. This segmentation allows each module to perform its specific function efficiently while maintaining overall system manageability and evaluation accuracy.
Data Source
AI summary
An auxiliary determination device for evaluating whether a transcranial magnetic stimulation (TMS) is effective for a patient with depression is provided. The device includes a feature extraction unit and a machine learning unit electrically connected thereto. In an interpretation mode, the feature extraction unit extracts a feature value from electroencephalography signals of the patient, and at least a classifier of the machine learning unit determines the efficacy of TMS for the patient according to the feature value of the electroencephalography signals. The electroencephalography signals are electroencephalography signals of the patient after being driven by a cognitive operation or a difference between electroencephalography signals before and after being driven by the cognitive operation, and the feature value is a linear or non-linear feature value. The auxiliary determination device of the invention can pre-evaluate the efficacy of TMS for the patient for avoiding ineffective treatment and unnecessary medical expense.


